Press Release

CREATIVE DIAGNOSTICS ANNOUNCES NEW MBC ASSAY FOR ANTIBACTERIAL TESTING READ MORE: HTTPS://WWW.DIGITALJOURNAL.COM/PR/NEWS/GETNEWS/CREATIVE-DIAGNOSTICS-ANNOUNCES-NEW-MBC-ASSAY-FOR-ANTIBACTERIAL-TESTING#IXZZ8KCL65CJI



Creative Diagnostics has announced the launch of its new Minimum Bactericidal Concentration (MBC) Assay for antibacterial testing.

FOR IMMEDIATE RELEASE

01/12/2023

As an expert in providing solutions to assist virology and microbiology research, Creative Diagnostics has announced the launch of its new Minimum Bactericidal Concentration (MBC) Assay for antibacterial testing. The new assay is a more accurate and sensitive measure of the effectiveness of antibiotics.

MBC is the lowest concentration of antimicrobial agent required to kill a specific bacterium. It can be determined by identifying the lowest concentration of antimicrobial agent that will reduce the survival of the initial bacterial inoculum by more than 99.9%.

In antimicrobial testing, the MBC complements the Minimum Inhibitory Concentration (MIC). The MIC test indicates the lowest level of an antimicrobial agent that inhibits the growth of a microorganism, whereas the MBC shows the lowest level of an antimicrobial agent that causes microbial death. This means that even if a particular MIC exhibits good bacterial inhibition, inoculation of bacteria onto agar may still result in bacterial proliferation because that concentration of antimicrobial does not result in complete bacterial death.

It is generally accepted that an antimicrobial agent is bactericidal if the MBC does not exceed four times the MIC. Because the MBC is the lowest concentration of the antimicrobial agent, it is expressed in micrograms per milliliter (µg/mL). If the MBC of the test drug against the test microorganism is ≧32 times the MIC, the microorganism is considered to be resistant to the test drug.

The MBC test can be used to determine the minimum reagent concentration required to achieve bactericidal efficacy. It is important to note that this method allows the antimicrobial agent to remain in contact with the test microorganism for an extended period of time, approximately 18 hours. Therefore, the test result is the minimum concentration required to kill the test organism, taking into account all other factors contributing to bactericidal activity.

Creative Diagnostics now offers comprehensive MBC Testing Services to the scientific community, including culturing to detect standard test bacteria, minimum bactericidal concentration testing, and statistical analysis of experimental results. This new MBC test is a reliable and relatively inexpensive tool for ranking a wide range of antimicrobials by potency for screening purposes, as well as for evaluating formulation problems, especially when formulators suspect that the active ingredient is influenced by other ingredients.

Creative Diagnostics' MBC detection utilizes a broth microdilution method. First, a pure culture of the specified microorganism is incubated overnight and then diluted to the appropriate concentration in a growth-supporting broth (usually Muller Hinton Broth). The compound to be tested is serially diluted and an equal volume of the specified microorganism is used to inoculate all dilutions of the compound to be tested. Test tubes or microtiter plates are then incubated at the appropriate temperature and time. Observations are then made and turbidity indicates microbial growth and the lowest concentration at which no bacterial growth can be visually detected, i.e., the MIC.

For more information, please visit https://antiviral.creative-diagnostics.com/minimum-bactericidal-concentration-mbc-assay.html.

About Creative Diagnostics

Headquartered in New York, Creative Diagnostics is a consulting and experimental service provider specializing in virology and microbiology. The company provides comprehensive solutions to conquer obstacles in virology and microbiology research, from high-security infrastructure provision, biosafety regulation elucidation, to expert viral system assistance.

Tags:
MBC Assay  |  Creative Diagnostics  |  

---

Organisation Profile:
Creative Diagnostics is a leading manufacturer and supplier of antibodies, viral antigens, innovative diagnostic components, and critical assay reagents. We provide contract biologic R&D and manufacturing services to the diagnostic manufacturers along with GMP biologics manufacturing for the biopharmaceutical market. Our goal is to be a trusted source for all your assay development and manufacturing needs.






Press release contact details for Creative Diagnostics

NameCreative Diagnostics
Tel
Fax
Email
Websitehttps://www.creative-diagnostics.com/
OrganisationCreative Diagnostics
Address
Town
County0
Postcode11967




Other press releases from Creative Diagnostics

Creative Diagnostics Launches HPV L1 Antibodies for Neutralization and Vaccine Development
Creative Diagnostics Introduces TCID50 Assay Service for Determining Viral Titers
Creative Diagnostics Introduces ELISA Kit Development Services to Support IVD Research
Creative Diagnostics Introduces Microneutralization Assay Service for Virus Detection
Creative Diagnostics Introduces Virus Yield Reduction Assay Service
Creative Diagnostics Introduces New Low Endotoxin Antibodies for Researchers
Creative Diagnostics Announces Calprotectin Reagents for Inflammatory Disease Research
Creative Diagnostics Introduces Viral Replicon Assay Service to Support Virology Research
Creative Diagnostics Announces the Launch of Radial Immunodiffusion Testing Service
Creative Diagnostics Launches Highly Specific Antibodies Against FXIIIa/F13A1 for Vascular Diseases
Creative Diagnostics Introduces qPCR Assay for Rapid Virus Detection and Quantification
Creative Diagnostics Launches New Reagent Solutions for Herpesvirus Research
Creative Diagnostics Announces New Reagents for Bioanalysis of Antibody Drug Conjugates
Creative Diagnostics Announces New Antimicrobial Susceptibility Testing Services
Creative Diagnostics Introduces New ELISA Kits to Accelerate Autoimmunity Research
Creative Diagnostics Launches Antimicrobial Synergy Testing Services
Creative Diagnostics Launches New Azaperone Test Reagents for Research Applications
Creative Diagnostics Launches Checkerboard Assay Services
Creative Diagnostics Launches New Anti-Small Molecule Label Antibodies to Facilitate NALFIA Development
Creative Diagnostics Announces New CLDN6 Solutions for Cancer Research
Creative Diagnostics Launches Minimum Inhibitory Concentration Testing Services
Creative Diagnostics Launches Carbamazepine Test Reagents
Creative Diagnostics Launches Macrophage Migration Inhibitory Factor Reagents for Research Applications
Creative Diagnostics Announces New Test Reagents for Dapsone
Creative Diagnostics Announces New MBC Assay for Antibacterial Testing Read more: https://www.digitaljournal.com/pr/news/getnews/creative-diagnostics-announces-new-mbc-assay-for-antibacterial-testing#ixzz8KcL65cji
Creative Diagnostics Announces New MBC Assay for Antibacterial Testing
Creative Diagnostics Launches Rapid Robenidine Test Reagents for the Analysis of Anticoccidial Residues
Creative Diagnostics Announces MDT Services for Measuring Antibacterial Effectiveness
Creative Diagnostics Launches New P53 and TP53 Antibodies for Cancer Research
Creative Diagnostics Launches Aflatoxin Test Reagents to Ensure Food Safety
Creative Diagnostics Launches Serum Plate Agglutination Test for In Vitro Detection of Multiple Pathogens
Creative Diagnostics Announces New AAV Reagent Solutions for Gene Therapy
Citrinin Test Reagents for Food Safety
Creative Diagnostics Announces Novel Agar Gel Precipitin Tests for Viral Antigen Detection
Creative Diagnostics Introduces Cutting-Edge Anti-AAV Antibody ELISA Kits for Gene Therapy Research
Creative Diagnostics Announces the Launch of Its Highly Sensitive Kanamycin ELISA Kit for Precise Antibiotic Detection
Creative Diagnostics Launches Comprehensive ELISA Based Assays for Vaccine Development
Creative Diagnostics Announces Comprehensive Vomitoxin Test Reagents for Food Safety Applications
High-Affinity Anti Venom Antibodies for Research Applications
Creative Diagnostics Introduces Immunofluorescence Assay Testing Services for Virology Research
Creative Diagnostics Launches Comprehensive Fumonisin Test Reagents for Precise Food Safety Analysis
Creative Diagnostics Introduces Comprehensive Range of Ochratoxin Test Reagents for Enhanced Food Safety Analysis
Creative Diagnostics Launches Plaque Reduction Assay Services to Advance Antiviral Research
Creative Diagnostics Announces the Launch of Norovirus VLP Antigens to Support Vaccine Research
Creative Diagnostics Introduces Patulin Test Reagents for Food Safety Applications
Creative Diagnostics Launches Reliable Hemagglutination Assay for Virus and Antibody Detection
Creative Diagnostics Announces High-Affinity Anti-Adenovirus Monoclonal Antibodies for Research and Assay Development

Disclaimer:
Issuers of the press releases are solely responsible for the content of their press releases. Connect2business.co.uk cannot be held liable for the content posted by others to this website.